Literature DB >> 10228075

Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease.

M J Blaser1.   

Abstract

Helicobacter pylori has apparently colonized the human stomach since time immemorial and is superbly adapted for persistence. Several genotypes, including cag+, are associated with increased risk of gastric and duodenal diseases. With modern life, for probably the first time in human history, there are large numbers of noncolonized persons. Duodenal ulceration has been present essentially for only 200 years; that its incidence rose just as H. pylori was waning is best explained by changes in gastric microecology. As H. pylori is disappearing, duodenal ulceration and gastric cancer rates are falling. However, more proximal diseases, gastroesophageal reflux (GERD), Barrett's esophagus, and adenocarcinomas of the gastric cardia and lower esophagus, are increasing; colonization with cag+ H. pylori strains appears protective against these diseases. Thus, in the 21st century, the continuing decline in H. pylori may lead to the disappearance of duodenal ulcers and distal gastric cancers and toward a marked increase in GERD, Barrett's esophagus, and esophageal adenocarcinoma.

Entities:  

Mesh:

Year:  1999        PMID: 10228075     DOI: 10.1086/314785

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  80 in total

Review 1.  Helicobacter pylori genetic diversity and risk of human disease.

Authors:  M J Blaser; D E Berg
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Vacuolating cytotoxin (vacA) alleles of Helicobacter pylori comprise two geographically widespread types, m1 and m2, and have evolved through limited recombination.

Authors:  J C Atherton; P M Sharp; T L Cover; G Gonzalez-Valencia; R M Peek; S A Thompson; C J Hawkey; M J Blaser
Journal:  Curr Microbiol       Date:  1999-10       Impact factor: 2.188

Review 3.  New approaches to Helicobacter pylori infection in children.

Authors:  B D Gold
Journal:  Curr Gastroenterol Rep       Date:  2001-06

4.  Helicobacter pylori is not and never was "protective" against anything, including GERD.

Authors:  David Y Graham
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

5.  Gastric cancer and H pylori.

Authors:  S M Dawsey; S D Mark; P R Taylor; P J Limburg
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 6.  Eradication of Helicobacter pylori: a clinical update.

Authors:  Marco Romano; Antonio Cuomo
Journal:  MedGenMed       Date:  2004-02-17

7.  Assessing the risks and benefits of treating Helicobacter pylori infection.

Authors:  Ivan F N Hung; Benjamin C Y Wong
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

Review 8.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

9.  Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization.

Authors:  Tomokazu Mizuno; Takafumi Ando; Kazuo Nobata; Tomoyuki Tsuzuki; Osamu Maeda; Osamu Watanabe; Masaaki Minami; Kenji Ina; Kazuo Kusugami; Richard M Peek; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

10.  Pathogenicty and immune prophylaxis of cag pathogenicity island gene knockout homogenic mutants.

Authors:  Huan-Jian Lin; Jing Xue; Yang Bai; Ji-De Wang; Ya-Li Zhang; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.